Drug intelligence / Profile preview

CP-744809

Development stage: Unknown
Modality: Small Molecules
Administration: Oral

Overview

CP-744809 is a chemical compound classified as a pharmaceutical. Its precise mechanism of action, primary indication, and developer are not publicly detailed in the available scientific literature or drug databases. It has been identified by its chemical structure (C13H9ClN2O4S) and is also known by the code name ARI-809.

Other names: 3-[(5-chloro-3-methyl-1-benzofuran-2-yl)sulfonyl]-1H-pyridazin-6-one463976-07-03(2H)-Pyridazinone, 6-((5-chloro-3-methyl-2-benzofuranyl)sulfonyl)-U63F8E95J1U-63F8E95J1U 63F8E95J16-(5-Chloro-3-methylbenzofuran-2-sulfonyl)-2H-pyridazin-3-one6-(5-Chloro-3-methylbenzofuran-2-ylsulfonyl)-2H-pyridazin-3-oneDTXSID70196828DTXSID-70196828DTXSID 701968286-CMeBzFSPORefChem:579361DTXCID10119319DTXCID-10119319DTXCID 10119319

Targets

AR (Adrenergic receptors)

Beyond the preview

Go deeper on CP-744809.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on CP-744809.

Explore the full profile